Clinical and microbiological analysis of bloodstream infections caused by Chryseobacterium meningosepticum in nonneonatal patients

Journal of Clinical Microbiology

Volumn 42, Issue 7, 2004, Pages 3353-3355

  Lin, Pen Yi ^a   Chu, Chishih ^a   Su, Lin Hui ^b   Huang, Chung Tsui ^a   Chang, Wen Ya ^a   Chiu, Cheng Hsun ^a  

^a CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFEPIME; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; MINOCYCLINE; PIPERACILLIN; RIFAMPICIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL GENETICS; BACTERIUM ISOLATE; CHRYSEOBACTERIUM; CHRYSEOBACTERIUM MENINGOSEPTICUM; CLINICAL EXAMINATION; DRUG ACTIVITY; ENZYME SYNTHESIS; FEMALE; GENOTYPE; HUMAN; INFANT; MALE; MINIMUM INHIBITORY CONCENTRATION; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SURVIVAL;

ADULT; AGED; BACTEREMIA; CHRYSEOBACTERIUM; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; POLYMERASE CHAIN REACTION;

BACTERIA (MICROORGANISMS); CHRYSEOBACTERIUM MENINGOSEPTICUM; NEGIBACTERIA;

EID: 3142732042     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.42.7.3353-3355.2004     Document Type: Article

References (19)

1. Bellais, S., L. Poirel, T. Naas, D. Girlich, and P. Nordmann. 2000. Genetic-biochemical analysis and distribution of the Ambler class A β-lactamase CME-2, responsible for extended spectrum cephalosporin resistance in Chryseobacterium (Flavobacterium) meningosepticum. Antimicrob. Agents Chemother. 44:1-9.
2. Bloch, K. C., R. Nadarajah, and R. Jacobs. 1997, Chryseobacterium meningosepticum: an emerging pathogen among immunocompromised adults. Medicine 76:30-41.
3. Chang, J. C., P. R. Hsueh, J. J. Wu, S. W. Ho, W. C. Hsieh, and K. T. Luh. 1997. Antimicrobial susceptibility of flavobacteria as determined by agar dilution and disk diffusion methods. Antimicrob. Agents Chemother. 41:1301-1306.
4. Chiu, C. H., M. Waddingdon, W. S. Hsieh, D. Greenberg, P. C. Schreckenberger, and A. M. Carnahan. 2000. Atypical Chryseobacterium meningosepticum and meningitis and sepsis in newborns and the immunocompromised, Taiwan. Emerg. Infect. Dis. 6:481-486.
5. Colding, H., J. Bangsborg, N. Fiehn, T. Bennekov, and B. Bruun. 1994. Ribotyping for differentiating Flavobacterium meningosepticum isolates from clinical and environmental sources. J. Clin. Microbiol. 32:501-505.
6. Hawley, H. B., and D. W. Gump. 1973. Vancomycin therapy of bacterial meningitis. Am. J. Dis. Child. 126:261-264.
7. Husson, M. O., D. Izard, L. Bouillet, and H. Lecherc. 1985. Comparative in-vitro activity of ciprofloxacin against non-fermenters. J. Antimicrob. Chemother. 15:457-462.
8. King, E. O. 1959. Studies of a group of previously unclassified bacteria associated with meningitis in infants. Am. J. Clin. Pathol. 31:241-247.
9. Maderazo, E. G., H. P. Bassaris, and R. Quintiliani. 1974. Flavobacterium meningosepticum meningitis in a newborn infant: treatment with intraventricular erythromycin. J. Pediatr. 85:675-676.
10. Mazurek, G. H., V. Reddy, B. J. Marston, W. H. Haas, and J. T. Crawford. 1996. DNA fingerprinting by infrequent-restriction-site amplification. J. Clin. Microbiol. 34:2386-2390.
11. Olson, H. W., W. C. Fredricksen, and K. E. Siboni. 1965. Flavobacterium meningosepticum in eight non-fatal cases of post-operative bacteremia. Lancet 1:1294-1296.
12. CME) encoding an extended-spectrum class A β-lactamase related to Bacteroides cephalosporinases and the VEB-1 and PER β-lactamases. Antimicrob. Agents Chemother. 43:2193-2199.
13. Su, L. H., H. S. Leu, Y. P. Chiu, J. H. Chia, A. J. Kuo, C. F. Sun, T. Y. Lin, and T. L. Wu. 2000. Molecular investigation of two clusters of nosocomial bacteraemia caused by multiresistant Klebsiella pneumoniae using pulsed-field gel electrophoresis and infrequent-restriction-site PCR. J. Hosp. Infect. 46:110-117.
14. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
15. Teres, D. 1974. ICU-acquired pneumonia due to Flavobacterium meningosepticum. JAMA 228:732.
16. Thong, M. L., S. D. Puthucheary, and E. Lee. 1981. Flavobacterium meningosepticum infection: an epidemiologic study in a newborn nursery. J. Clin. Pathol. 34:429-433.
17. Ursing, J., and B. Bruun. 1987. Genetic heterogeneity of Flavobacterium meningosepticum demonstrated by DNA-DNA hybridization. Acta Pathol. Microbiol. Immunol. Scand. Sect. B 95:33-39.
18. Werthamer, S., and M. Weiner. 1971. Subacute bacterial endocarditis due to Flavobacterium meningosepticum. Am. J. Clin. Pathol. 57:410-412.
19. Woodford, N., M. I. Palepou, G. S. Babini, B. Holmes, and D. M. Livermore. 2000. Carbapenemases of Chryseobacterium (Flavobacterium) meningosepticum: distribution of blaB and characterization of a novel metallo-β-lactamase gene, blaB3, in the type strain, NCTC 10016. Antimicrob. Agents Chemother. 44:1448-1452.